Intellia Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NTLA research report →
About the company
Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing. The company's pipeline includes several in vivo (administered within the body) programs.
- CEO
- John Leonard
- IPO
- 2016
- Employees
- 403
- HQ
- Cambridge, MA, US
Price Chart
- Market Cap
- $1.97B
- P/E
- -4.96
- P/S
- 29.81
- P/B
- 3.35
- EV/EBITDA
- -4.98
- Div Yield
- 0.00%
- Gross Margin
- -153.74%
- Op Margin
- -636.56%
- Net Margin
- -597.04%
- ROE
- -57.27%
- ROIC
- -59.98%
- Revenue
- $67.67M · 16.92%
- Net Income
- $-412,694,000 · 20.49%
- EPS
- $-3.81 · 27.43%
- Op Income
- $-440,990,000
- FCF YoY
- 0.00%
- 52W High
- $28.25
- 52W Low
- $7.95
- 50D MA
- $14.09
- 200D MA
- $13.68
- Beta
- 1.81
- Avg Volume
- 6.56M
Get TickerSpark's AI analysis on NTLA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | Verwiel Frank | other | 9,200 |
| Jun 9, 26 | Verwiel Frank | other | 13,300 |
| Jun 9, 26 | Keresty Georgia | other | 9,200 |
| Jun 9, 26 | Keresty Georgia | other | 13,300 |
| Jun 9, 26 | GOODMAN JESSE | other | 9,200 |
| Jun 9, 26 | GOODMAN JESSE | other | 13,300 |
| Jun 9, 26 | Goff Brian | other | 9,200 |
| Jun 9, 26 | Goff Brian | other | 13,300 |
| Jun 9, 26 | Cohen Fred E | other | 9,200 |
| Jun 9, 26 | Cohen Fred E | other | 13,300 |
Our NTLA coverage
Recent articles, reports, and earnings notes.
Want a deeper read on NTLA?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.